The Conversation (0)
Business Standard reports that RPG Life Sciences (NSE::RPGLIFE) gained 18 percent on the National Stock Exchange of India (NSE) after returning to profit in the fourth quarter ended March 31st.
Business Standard reports that RPG Life Sciences (NSE::RPGLIFE) gained 18 percent on the National Stock Exchange of India (NSE) after returning to profit in the fourth quarter ended March 31st.
Q4 net profit was Rs 7.40 crore versus Rs 5.69 crore in the year-ago quarter.
As reported in the market news:
“The investments made in upgradation of manufacturing facility, formulation business, during the year constrained the profitability,” said Ajit Singh Chouhan, managing director of the company.
RPG is involved in a range of branded formulations, generics and bulk drugs developed through fermentation and chemical synthesis.